Mirae Asset Global Etfs Holdings Ltd. Surmodics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Surmodics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 8,176 shares of SRDX stock, worth $243,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,176
Previous 7,849
4.17%
Holding current value
$243,644
Previous $310,000
19.68%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SRDX
# of Institutions
140Shares Held
12.1MCall Options Held
31.3KPut Options Held
17.9K-
Black Rock Inc. New York, NY1.17MShares$34.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY849KShares$25.3 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$23.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT789KShares$23.5 Million1.99% of portfolio
-
Morgan Stanley New York, NY676KShares$20.1 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $417M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...